| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/22/1993 | US5221796 Isoprenoid type phospholipid excellent in biological compatibility, dispersibility and chemical stability |
| 06/22/1993 | US5221722 Crosslinked polyacrylic acid |
| 06/22/1993 | US5221698 Bioactive composition |
| 06/22/1993 | US5221696 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs |
| 06/22/1993 | US5221537 Tissue irrigating solutions |
| 06/22/1993 | US5221536 Useful for treating Perkinson's disease; as an osmatic device |
| 06/22/1993 | US5221535 Sustained release formulations of insect repellent |
| 06/22/1993 | US5221278 Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
| 06/22/1993 | CA1319322C Azelastine-containing medicaments for application in the nose and/or eye |
| 06/22/1993 | CA1319321C Pharmaceutical preparations |
| 06/21/1993 | CA2085799A1 Compositions for the treatment of mammalian diseases |
| 06/21/1993 | CA2085782A1 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals |
| 06/21/1993 | CA2085639A1 Lip treatment composition |
| 06/20/1993 | WO1993011753A1 Solvent system to be enclosed in capsules |
| 06/20/1993 | CA2085690A1 Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| 06/19/1993 | WO1993011751A1 Lubricous polymer network |
| 06/19/1993 | CA2100970A1 Lubricous polyer network |
| 06/17/1993 | DE4240146A1 Inserting microcapsules contg. pharmaceutical or technical active agents in carrier mass - useful, e.g., in prodn. of retard forms of pharmaceutical active agents |
| 06/17/1993 | DE4140689A1 Inhalationspulver und verfahren zu ihrer herstellung Inhalation powder and process for their production |
| 06/17/1993 | DE4140195A1 Stable nano-sol of sparingly water soluble pharmaceutical - has external phase of gelatin selected to balance charge on drug particle to improve bioavailability |
| 06/17/1993 | DE4140183A1 Retardform fuer ein flurbiprofen enthaltendes arzneimittel und seine herstellung Release form for a drug-containing flurbiprofen and its manufacture |
| 06/17/1993 | DE4140172A1 Retardform fuer ein ibuprofen enthaltendes arzneimittel und seine herstellung Release form for an ibuprofen-containing drug and its manufacture |
| 06/16/1993 | EP0547000A1 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound |
| 06/16/1993 | EP0546951A1 Combination of liposome encapsulated antineoplastic agents, such as doxorubicin with colony stimulating factors |
| 06/16/1993 | EP0546846A1 Programmed-release pharmaceutical compositions |
| 06/16/1993 | EP0546810A1 Carboxyvinyl polymer having Newtonian viscosity |
| 06/16/1993 | EP0546796A1 Treatment of Atherosclerosis |
| 06/16/1993 | EP0546728A2 Physiological tear compositions and methods for their preparation |
| 06/16/1993 | EP0546721A1 Treating lignocellulosic materials |
| 06/16/1993 | EP0546593A1 Multi-layered compositions containing histamine or serotonin antagonists |
| 06/16/1993 | EP0546358A2 Pharmaceutical compositions with angiotensin-II-antagonistic activity |
| 06/16/1993 | EP0546160A1 Method of reversing local anesthesia and reagent system therefor |
| 06/16/1993 | EP0546158A1 Capsule extrusion systems |
| 06/16/1993 | EP0546075A1 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic |
| 06/16/1993 | EP0546063A1 Toxic agent protective compounds, compositions and uses |
| 06/16/1993 | EP0546020A1 Slow release compositions |
| 06/16/1993 | EP0486499A4 Stable ascorbic acid compositions |
| 06/16/1993 | EP0352295B1 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
| 06/16/1993 | CN1073172A Ethanol additive compound of 6-sulfonyl substituted 3-carboxy benzo dihydro-pyran and used as inhalant for patient |
| 06/16/1993 | CN1073104A Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
| 06/16/1993 | CN1073103A Prescription for curing thrombus capsule and its technology |
| 06/16/1993 | CN1073094A Pharmaceutical composition containing felbinac |
| 06/16/1993 | CN1021197C Veterinary device |
| 06/16/1993 | CN1021196C Prepn. method of progestin unit and system |
| 06/15/1993 | US5219980 Unsaturated polyester modified by an amine in a Michael Condensation reaction; drug delivery; bandages; protective coatings for metals; resists for semiconductors |
| 06/15/1993 | US5219870 Antiulcer agents |
| 06/15/1993 | US5219844 Combination of perfluorocarbon liquid and silicone and method of treating disorders of an eye with the combination |
| 06/15/1993 | US5219621 Methods of treatment with diltiazem formulations |
| 06/15/1993 | US5219577 Biologically active composition having a nanocrystalline core |
| 06/15/1993 | US5219575 Core or protective layer coated with continuous matrix of constant composition having concentration gradient of active substance and excipient |
| 06/15/1993 | US5219574 Magnesium carbonate and oil tableting aid and flavoring additive |
| 06/15/1993 | US5219572 Beadlets of non-uniform rupture time ssurrounded by water soluble capsule |
| 06/15/1993 | US5219571 Applying bentonite dispersed in lipophilic agent |
| 06/15/1993 | US5219570 Laxatives; maltodetrin coating |
| 06/15/1993 | US5219563 Contacting synthetic cation exchange resin with ranitidine or salt to form complex |
| 06/15/1993 | US5219538 Gas and oxygen carrying lipid vesicles |
| 06/15/1993 | US5219328 Fibrin sealant delivery method |
| 06/15/1993 | CA2085200A1 Pharmaceutical composition |
| 06/15/1993 | CA2085166A1 Ethanol adducts of 6-sulfonyl-substituted 3-hydroxychromans and their use as inhalants in diseases |
| 06/15/1993 | CA1319111C Anti-acne composition |
| 06/15/1993 | CA1319110C Pharmaceutical composition comprising exifone and water-soluble polymer |
| 06/15/1993 | CA1319109C Spray dried ibuprofen |
| 06/15/1993 | CA1319108C Drug delivery devices |
| 06/15/1993 | CA1319106C Antacid composition |
| 06/15/1993 | CA1319104C Skin permeation enhancer compositions using sucrose esters |
| 06/15/1993 | CA1319103C Ocular delivery of prophylactic agents |
| 06/15/1993 | CA1319071C Dispenser with movable matrix comprising a plurality of tiny pills |
| 06/15/1993 | CA1318988C Polysaccharide-based composition and its use |
| 06/14/1993 | CA2085149A1 Carboxyvinyl polymer having newtonian viscosity |
| 06/13/1993 | WO1993011776A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/13/1993 | CA2124565A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/13/1993 | CA2085142A1 Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore |
| 06/10/1993 | WO1993010809A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | WO1993010797A1 Dimeticon pastilles |
| 06/10/1993 | WO1993010793A1 Antivirus agent |
| 06/10/1993 | WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | WO1993010782A1 Pharmaceutical compositions based on ebastime or analogues thereof |
| 06/10/1993 | WO1993010775A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 06/10/1993 | WO1993010772A1 Transdermal estradiol delivery system |
| 06/10/1993 | WO1993010771A1 Slow-release flurbiprofen-containing medicament and its use |
| 06/10/1993 | WO1993010770A1 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation |
| 06/10/1993 | WO1993010769A1 Slow-release pharmaceutic form of a medicament containing 3-indolylacetic acid derivate and its preparation |
| 06/10/1993 | WO1993010768A1 Pharmaceutically applicable nanosol and process for preparing the same |
| 06/10/1993 | WO1993010767A1 Peroral administration form for peptidic medicaments, in particular insulin |
| 06/10/1993 | WO1993010766A1 Immediate-effect flurbiprofen-containing medicament and its use |
| 06/10/1993 | WO1993010764A1 Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms |
| 06/10/1993 | WO1993010763A1 Antitumor vaccines |
| 06/10/1993 | WO1993010762A1 Immediate-effect ibuprofen-containing medicament and its use |
| 06/10/1993 | WO1993010761A1 Medicament containing a 2-arylpropionic acid derivate as a nanosol and its preparation |
| 06/10/1993 | WO1993010760A1 Slow-release ibuprofen-containing medicament and its use |
| 06/10/1993 | WO1993010758A1 A carbohydrate glass matrix for the sustained release of a therapeutic agent |
| 06/10/1993 | WO1993010757A1 Pharmaceutical composition |
| 06/10/1993 | WO1993003714A3 Method for treatment of metabolic disorders |
| 06/10/1993 | CA2125156A1 Pharmaceutical composition |
| 06/10/1993 | CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | CA2124209A1 A new preparation with an acrylic-based adhesive copolymeric matrix for the transdermal delivery of estradiol |
| 06/10/1993 | CA2123677A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 06/10/1993 | CA2121904A1 Dimeticon pastilles |
| 06/09/1993 | EP0545913A1 Delivery systems for pharmacological agents |